Have a personal or library account? Click to login
Current Management of Neurological Wilson’s Disease Cover

Current Management of Neurological Wilson’s Disease

Tremor and Other Hyperkinetic Movements
Volume 15 (2025): Issue 1
By: V. H. GanarajaORCID,  Vikram V. HollaORCID and  Pramod Kumar PalORCID  
Open Access
|May 2025

References

  1. 1Kasztelan-Szczerbinska B, Cichoz-Lach H. Wilson’s Disease: An Update on the Diagnostic Workup and Management. J Clin Med [Internet]. 2021 [cited 2024 May 24];10. Available from: https://pubmed.ncbi.nlm.nih.gov/34768617/. DOI: 10.3390/jcm10215097
    Back to article
  2. 2Alkhouri N, Gonzalez-Peralta RP, Medici V. Wilson disease: a summary of the updated AASLD Practice Guidance. Hepatol Commun [Internet]. 2023 [cited 2025 Feb 2];7. Available from: https://pubmed.ncbi.nlm.nih.gov/37184530/. DOI: 10.1097/HC9.0000000000000150
    Back to article
  3. 3Chu NS, Hung TP. Geographic variations in Wilson’s disease. J Neurol Sci [Internet]. 1993 [cited 2024 May 24];117:1–7. Available from: https://pubmed.ncbi.nlm.nih.gov/8410043/. DOI: 10.1016/0022-510X(93)90145-O
    Back to article
  4. 4Jang ES, Choi HY, Ki M, Kim BH, Kim K-A, Jeong S-H. Prevalence, Incidence, and Treatment Pattern of Wilson’s Disease Using National Health Insurance Data From 2010–2020, Korea. J Korean Med Sci. 2024;39. DOI: 10.3346/jkms.2024.39.e115
    Back to article
  5. 5Abbassi N, Bourrahouat A, Bedoya EC, Pagan C, Qabli M El, Maidoumi S, et al. Phenotype and molecular characterization of Wilson’s disease in Morocco. Clin Res Hepatol Gastroenterol. 2024;48:102335. DOI: 10.1016/j.clinre.2024.102335
    Back to article
  6. 6Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med [Internet]. 2019 [cited 2024 May 24];7:S67–S67. Available from: https://pubmed.ncbi.nlm.nih.gov/31179304/. DOI: 10.21037/atm.2019.02.10
    Back to article
  7. 7Abbassi N, Bourrahouat A, Bedoya EC, Pagan C, Qabli M El, Maidoumi S, et al. Phenotype and molecular characterization of Wilson’s disease in Morocco. Clin Res Hepatol Gastroenterol [Internet]. 2024 [cited 2025 Feb 2];48. Available from: https://pubmed.ncbi.nlm.nih.gov/38588792/. DOI: 10.1016/j.clinre.2024.102335
    Back to article
  8. 8Wilson SAK. Progressive Lenticular Degeneration: A Familial Nervous Disease Associated With Cirrhosis Of The Liver. Brain [Internet]. 1912 [cited 2024 May 24];34:295–507. DOI: 10.1093/brain/34.4.295
    Back to article
  9. 9Walshe JM. The conquest of Wilsons disease. Brain. 2009;132:2289–95. DOI: 10.1093/brain/awp149
    Back to article
  10. 10Wiernicka A, Dadalski M, Jańczyk W, Kamińska D, Naorniakowska M, Hüsing-Kabar A, et al. Early Onset of Wilson Disease: Diagnostic Challenges. J Pediatr Gastroenterol Nutr [Internet]. 2017 [cited 2025 Feb 2];65:555–60. Available from: https://pubmed.ncbi.nlm.nih.gov/28753182/. DOI: 10.1097/MPG.0000000000001700
    Back to article
  11. 11Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine [Internet]. 2007 [cited 2025 Feb 2];86:112–21. Available from: https://pubmed.ncbi.nlm.nih.gov/17435591/. DOI: 10.1097/MD.0b013e318045a00e
    Back to article
  12. 12Singh N, Kallollimath P, Shah MH, Kapoor S, Bhat VK, Viswanathan LG, et al. Genetic analysis of ATP7B in 102 south Indian families with Wilson disease. PLoS One [Internet]. 2019 [cited 2025 Feb 2];14. Available from: https://pubmed.ncbi.nlm.nih.gov/31059521/. DOI: 10.1371/journal.pone.0215779
    Back to article
  13. 13Soltanzadeh A, Soltanzadeh P, Nafissi S, Ghorbani A, Sikaroodi H, Lotfi J. Wilson’s disease: a great masquerader. Eur Neurol [Internet]. 2007 [cited 2024 May 24];57:80–5. Available from: https://pubmed.ncbi.nlm.nih.gov/17179709/. DOI: 10.1159/000098056
    Back to article
  14. 14Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine [Internet]. 2007 [cited 2024 May 24];86:112–21. Available from: https://pubmed.ncbi.nlm.nih.gov/17435591/. DOI: 10.1097/MD.0b013e318045a00e
    Back to article
  15. 15Jung KH, Ahn TB, Jeon BS. Wilson disease with an initial manifestation of polyneuropathy. Arch Neurol [Internet]. 2005 [cited 2024 May 24];62:1628–31. Available from: https://pubmed.ncbi.nlm.nih.gov/16216950/. DOI: 10.1001/archneur.62.10.1628
    Back to article
  16. 16Ferenci P. Phenotype-genotype correlations in patients with Wilson’s disease. Ann N Y Acad Sci [Internet]. 2014 [cited 2024 May 24];1315:1–5. Available from: https://pubmed.ncbi.nlm.nih.gov/24517292/. DOI: 10.1111/nyas.12340
    Back to article
  17. 17Singh N, Kallollimath P, Shah MH, Kapoor S, Bhat VK, Viswanathan LG, et al. Genetic analysis of ATP7B in 102 south Indian families with Wilson disease. PLoS One [Internet]. 2019 [cited 2024 May 24];14:e0215779. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0215779. DOI: 10.1371/journal.pone.0215779
    Back to article
  18. 18Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJG, et al. Evaluation of the Unified Wilson’s Disease Rating Scale (UWDRS) in German patients with treated Wilson’s disease. Mov Disord [Internet]. 2008 [cited 2024 May 24];23:54–62. Available from: https://pubmed.ncbi.nlm.nih.gov/17960799/. DOI: 10.1002/mds.21761
    Back to article
  19. 19Aggarwal A, Aggarwal N, Nagral A, Jankharia G, Bhatt M. A novel global assessment scale for Wilson’s disease (GAS for WD). Movement Disorders. 2009;24:509–18. DOI: 10.1002/mds.22231
    Back to article
  20. 20Mohr I, Weiss KH. Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. Clin Biochem Rev [Internet]. 2019 [cited 2024 May 24];40:59–77. Available from: https://pubmed.ncbi.nlm.nih.gov/31205375/. DOI: 10.33176/AACB-18-00014
    Back to article
  21. 21Mak CM, Lam CW, Tam S. Diagnostic accuracy of serum ceruloplasmin in Wilson disease: determination of sensitivity and specificity by ROC curve analysis among ATP7B-genotyped subjects. Clin Chem [Internet]. 2008 [cited 2024 May 24];54:1356–62. Available from: https://pubmed.ncbi.nlm.nih.gov/18556333/. DOI: 10.1373/clinchem.2008.103432
    Back to article
  22. 22Walshe JM. Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease. Mov Disord [Internet]. 2005 [cited 2025 Feb 2];20:1658–61. Available from: https://pubmed.ncbi.nlm.nih.gov/16092117/. DOI: 10.1002/mds.20628
    Back to article
  23. 23Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med [Internet]. 1991 [cited 2024 May 24];115:720–6. Available from: https://pubmed.ncbi.nlm.nih.gov/1929042/. DOI: 10.7326/0003-4819-115-9-720
    Back to article
  24. 24Gaffney D, Fell GS, O’Reilly DSJ. Wilson’s disease: acute and presymptomatic laboratory diagnosis and monitoring. J Clin Pathol [Internet]. 2000 [cited 2024 May 24];53:807. Available from: /pmc/articles/PMC1731102/. DOI: 10.1136/jcp.53.11.807
    Back to article
  25. 25Salman HM, Amin M, Syed J, Sarfraz Z, Sarfraz A, Sarfraz M, et al. Biochemical testing for the diagnosis of Wilson’s disease: A systematic review. J Clin Lab Anal. 2022;36. DOI: 10.1002/jcla.24191
    Back to article
  26. 26Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut [Internet]. 2007 [cited 2024 May 24];56:115–20. Available from: https://pubmed.ncbi.nlm.nih.gov/16709660/. DOI: 10.1136/gut.2005.087262
    Back to article
  27. 27Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int [Internet]. 2003 [cited 2024 May 24];23:139–42. Available from: https://pubmed.ncbi.nlm.nih.gov/12955875/. DOI: 10.1034/j.1600-0676.2003.00824.x
    Back to article
  28. 28Dzieżyc K, Litwin T, Chabik G, Członkowska A. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson’s disease. Funct Neurol [Internet]. 2015 [cited 2025 Feb 2];30:264–8. Available from: https://pubmed.ncbi.nlm.nih.gov/26727705/. DOI: 10.11138/FNeur/2015.30.4.264
    Back to article
  29. 29Boaru SG, Merle U, Uerlings R, Zimmermann A, Flechtenmacher C, Willheim C, et al. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson’s disease. J Cell Mol Med [Internet]. 2015 [cited 2024 May 24];19:806. Available from: /pmc/articles/PMC4395195/. DOI: 10.1111/jcmm.12497
    Back to article
  30. 30Mahale RR, Stezin A, Prasad S, Kamble N, Holla VV., Netravathi M, et al. Clinical Spectrum, Radiological Correlation and Outcome of Movement Disorders in Wilson’s Disease. Tremor Other Hyperkinet Mov (N Y) [Internet]. 2023 [cited 2024 May 24];13. Available from: https://pubmed.ncbi.nlm.nih.gov/37840995/. DOI: 10.5334/tohm.794
    Back to article
  31. 31Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson’s disease: cranial MRI observations and clinical correlation. Neuroradiology [Internet]. 2006 [cited 2024 May 24];48:613–21. Available from: https://pubmed.ncbi.nlm.nih.gov/16752136/. DOI: 10.1007/s00234-006-0101-4
    Back to article
  32. 32Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK. Sequential MRI changes in Wilson’s disease with de-coppering therapy: a study of 50 patients. Br J Radiol [Internet]. 2007 [cited 2025 Feb 2];80:744–9. Available from: https://pubmed.ncbi.nlm.nih.gov/17709362/. DOI: 10.1259/bjr/48911350
    Back to article
  33. 33Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Primers [Internet]. 2018 [cited 2025 Feb 2];4. Available from: https://pubmed.ncbi.nlm.nih.gov/30190489/. DOI: 10.1038/s41572-018-0018-3
    Back to article
  34. 34Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: Impact on genetic testing. Hum Genet. 2006;120:151–9. DOI: 10.1007/s00439-006-0202-5
    Back to article
  35. 35Aggarwal A, Chandhok G, Todorov T, Parekh S, Tilve S, Zibert A, et al. Wilson disease mutation pattern with genotype-phenotype correlations from Western India: Confirmation of p.C271* as a common indian mutation and identification of 14 novel mutations. Ann Hum Genet. 2013;77:299–307. DOI: 10.1111/ahg.12024
    Back to article
  36. 36Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, et al. A genetic study of Wilson’s disease in the United Kingdom. Brain. 2013;136:1476–87. DOI: 10.1093/brain/awt035
    Back to article
  37. 37Schmidt HHJ. Role of genotyping in Wilson’s disease. J Hepatol. 2009;50:449–52. DOI: 10.1016/j.jhep.2008.11.008
    Back to article
  38. 38Bennett JT, Schwarz KB, Swanson PD, Hahn SH. An exceptional family with three consecutive generations affected by Wilson disease. JIMD Rep [Internet]. 2013 [cited 2024 May 24];10:79–82. Available from: https://pubmed.ncbi.nlm.nih.gov/23430806/. DOI: 10.1007/8904_2012_206
    Back to article
  39. 39Hartwig C, Zlatic SA, Wallin M, Vrailas-Mortimer A, Fahrni CJ, Faundez V. Trafficking mechanisms of P-type ATPase copper transporters. Curr Opin Cell Biol [Internet]. 2019 [cited 2024 May 24];59:24–33. Available from: https://pubmed.ncbi.nlm.nih.gov/30928671/. DOI: 10.1016/j.ceb.2019.02.009
    Back to article
  40. 40Ovchinnikova EV, Garbuz MM, Ovchinnikova AA, Kumeiko VV. Epidemiology of Wilson’s Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. Int J Mol Sci [Internet]. 2024 [cited 2024 Jul 5];25. Available from: /pmc/articles/PMC10889319/. DOI: 10.3390/ijms25042402
    Back to article
  41. 41Chang IJ, Hahn SH. The genetics of Wilson disease. Handb Clin Neurol. 2017;142:19–34. DOI: 10.1016/B978-0-444-63625-6.00003-3
    Back to article
  42. 42Ferenci P. Phenotype-genotype correlations in patients with Wilson’s disease. Ann N Y Acad Sci [Internet]. 2014 [cited 2025 Feb 3];1315:1–5. Available from: https://pubmed.ncbi.nlm.nih.gov/24517292/. DOI: 10.1111/nyas.12340
    Back to article
  43. 43Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet [Internet]. 1997 [cited 2025 Feb 3];61:317–28. Available from: https://pubmed.ncbi.nlm.nih.gov/9311736/. DOI: 10.1086/514864
    Back to article
  44. 44Chang IJ, Hahn SH. The genetics of Wilson disease. Handb Clin Neurol [Internet]. 2017 [cited 2025 Feb 3];142:19–34. Available from: https://pubmed.ncbi.nlm.nih.gov/28433102/. DOI: 10.1016/B978-0-444-63625-6.00003-3
    Back to article
  45. 45Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet [Internet]. 1997 [cited 2024 May 24];61:317. Available from: /pmc/articles/PMC1715895/?report=abstract. DOI: 10.1086/514864
    Back to article
  46. 46Singh N, Kallollimath P, Shah MH, Kapoor S, Bhat VK, Viswanathan LG, et al. Genetic analysis of ATP7B in 102 south Indian families with Wilson disease. PLoS One [Internet]. 2019 [cited 2024 May 24];14:e0215779. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0215779. DOI: 10.1371/journal.pone.0215779
    Back to article
  47. 47Xue Z, Chen H, Yu L, Jiang P. A Systematic Review and Meta-Analysis of the R778L Mutation in ATP7B With Wilson Disease in China. Pediatr Neurol [Internet]. 2023 [cited 2024 Jul 5];145:135–47. Available from: https://pubmed.ncbi.nlm.nih.gov/37354629/. DOI: 10.1016/j.pediatrneurol.2023.04.026
    Back to article
  48. 48Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, et al. Wilson’s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol [Internet]. 2019 [cited 2024 May 24];9:74–98. Available from: https://pubmed.ncbi.nlm.nih.gov/30765941/. DOI: 10.1016/j.jceh.2018.08.009
    Back to article
  49. 49Antos A, Litwin T, Skowronska M, Kurkowska-Jastrzebska I, Czlonkowska A. Pitfalls in diagnosing Wilson’s Disease by genetic testing alone: the case of a 47-year-old woman with two pathogenic variants of the ATP7B gene. Neurol Neurochir Pol [Internet]. 2020 [cited 2024 May 24];54:478–80. Available from: https://pubmed.ncbi.nlm.nih.gov/32808274/. DOI: 10.5603/PJNNS.a2020.0063
    Back to article
  50. 50Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology [Internet]. 2008 [cited 2024 May 24];47:2089–111. Available from: https://pubmed.ncbi.nlm.nih.gov/18506894/. DOI: 10.1002/hep.22261
    Back to article
  51. 51Arn PH. Newborn screening: Current status. Health Aff. 2007;26:559–66. DOI: 10.1377/hlthaff.26.2.559
    Back to article
  52. 52Owada M, Suzuki K, Fukushi M, Yamauchi K, Kitagawa T. Mass screening for Wilson’s disease by measuring urinary holoceruloplasmin. J Pediatr [Internet]. 2002 [cited 2024 May 24];140:614–6. Available from: https://pubmed.ncbi.nlm.nih.gov/12032531/. DOI: 10.1067/mpd.2002.122731
    Back to article
  53. 53Chenbhanich J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, Cheungpasitporn W. Osteoporosis and bone mineral density in patients with Wilson’s disease: a systematic review and meta-analysis. Osteoporosis International. 2018;29:315–22. DOI: 10.1007/s00198-017-4295-6
    Back to article
  54. 54Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: A review of what we have learned. World J Hepatol [Internet]. 2015 [cited 2024 May 24];7:2859–70. Available from: https://pubmed.ncbi.nlm.nih.gov/26692151/. DOI: 10.4254/wjh.v7.i29.2859
    Back to article
  55. 55Członkowska A, Rodo M, Wierzchowska-Ciok A, Smolinski L, Litwin T. Accuracy of the radioactive copper incorporation test in the diagnosis of Wilson disease. Liver Int [Internet]. 2018 [cited 2024 May 24];38:1860–6. Available from: https://pubmed.ncbi.nlm.nih.gov/29418065/. DOI: 10.1111/liv.13715
    Back to article
  56. 56Aggarwal A, Bhatt M. The Pragmatic Treatment of Wilson’s Disease. Mov Disord Clin Pract. 2014;1:14–23. DOI: 10.1002/mdc3.12003
    Back to article
  57. 57Ferenci P, Steindl-Munda P, Vogel W, Jessner W, Gschwantler M, Stauber R, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson’s Disease. Clin Gastroenterol Hepatol [Internet]. 2005 [cited 2024 May 24];3:811–8. Available from: https://pubmed.ncbi.nlm.nih.gov/16234011/. DOI: 10.1016/S1542-3565(05)00181-3
    Back to article
  58. 58Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson’s disease: An experience over three decades. Gut. 2000;46:415–9. DOI: 10.1136/gut.46.3.415
    Back to article
  59. 59Garoufalia Z, Prodromidou A, Machairas N, Kostakis ID, Stamopoulos P, Zavras N, et al. Liver Transplantation for Wilson’s Disease in Non-adult Patients: A Systematic Review. Transplant Proc. 2019;51:443–5. DOI: 10.1016/j.transproceed.2019.01.017
    Back to article
  60. 60Litwin T, Dusek P, Antos A, Członkowska A, Bembenek J. Tackling the neurological manifestations in Wilson’s disease – currently available treatment options. Expert Rev Neurother. 2023;23:1249–59. DOI: 10.1080/14737175.2023.2268841
    Back to article
  61. 61Roberts EA, Schilsky ML. Current and Emerging Issues in Wilson’s Disease. New England Journal of Medicine. 2023;389:922–38. DOI: 10.1056/NEJMra1903585
    Back to article
  62. 62Socha P, Janczyk W, Dhawan A, Baumann U, D’Antiga L, Tanner S, et al. Wilson’s Disease in Children. J Pediatr Gastroenterol Nutr. 2018;66:334–44. DOI: 10.1097/MPG.0000000000001787
    Back to article
  63. 63Walshe JM. The story of penicillamine: a difficult birth. Mov Disord [Internet]. 2003 [cited 2024 May 24];18:853–9. Available from: https://pubmed.ncbi.nlm.nih.gov/12889074/. DOI: 10.1002/mds.10458
    Back to article
  64. 64Beinhardt S, Leiss W, Stättermayer AF, Graziadei I, Zoller H, Stauber R, et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol [Internet]. 2014 [cited 2024 May 24];12:683–9. Available from: https://pubmed.ncbi.nlm.nih.gov/24076416/. DOI: 10.1016/j.cgh.2013.09.025
    Back to article
  65. 65Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, et al. Wilson’s disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut [Internet]. 2001 [cited 2024 May 24];48:849–52. Available from: https://pubmed.ncbi.nlm.nih.gov/11358907/. DOI: 10.1136/gut.48.6.849
    Back to article
  66. 66Członkowska A, Litwin T. Wilson disease – currently used anticopper therapy. Handb Clin Neurol [Internet]. 2017 [cited 2024 May 24];142:181–91. Available from: https://www.researchgate.net/publication/316329791_Wilson_disease_-_currently_used_anticopper_therapy. DOI: 10.1016/B978-0-444-63625-6.00015-X
    Back to article
  67. 67Roberts EA, Socha P. Wilson disease in children. Handb Clin Neurol [Internet]. 2017 [cited 2024 May 24];142:141–56. Available from: https://pubmed.ncbi.nlm.nih.gov/28433098/. DOI: 10.1016/B978-0-444-63625-6.00012-4
    Back to article
  68. 68Mbala J, Belmalih A, Guillaud O, Lachaux A, Couchonnal Bedoya E. Evaluation of vitamin B6 supplementation in Wilson’s disease patients treated with D-penicillamine. BMJ Open Gastroenterol. 2023;10:e001211. DOI: 10.1136/bmjgast-2023-001211
    Back to article
  69. 69Antos A, Członkowska A, Smolinski L, Bembenek J, Przybyłkowski A, Skowrońska M, et al. Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis. Neurological Sciences. 2023;44:3443–55. DOI: 10.1007/s10072-023-06895-6
    Back to article
  70. 70Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology [Internet]. 2022 [cited 2025 Feb 2]; Available from: https://pubmed.ncbi.nlm.nih.gov/36151586/. DOI: 10.1002/hep.32801
    Back to article
  71. 71Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson’s disease. J Clin Pharm Ther [Internet]. 2007 [cited 2024 May 24];32:101–7. Available from: https://pubmed.ncbi.nlm.nih.gov/17286794/. DOI: 10.1111/j.1365-2710.2007.00794.x
    Back to article
  72. 72Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson’s disease. N Engl J Med [Internet]. 1987 [cited 2024 May 24];317:209–13. Available from: https://pubmed.ncbi.nlm.nih.gov/3600712/. DOI: 10.1056/NEJM198707233170405
    Back to article
  73. 73Yarze JC, Martin P, Muñoz SJ, Friedman LS. Wilson’s disease: current status. Am J Med [Internet]. 1992 [cited 2024 May 24];92:643–54. Available from: https://pubmed.ncbi.nlm.nih.gov/1605146/. DOI: 10.1016/0002-9343(92)90783-8
    Back to article
  74. 74Chevalier K, Obadia MA, Djebrani-Oussedik N, Poujois A. Can Patients with Wilson’s Disease Develop Copper Deficiency? Mov Disord Clin Pract. 2023;10:1306–16. DOI: 10.1002/mdc3.13813
    Back to article
  75. 75Perry AR, Pagliuca A, Fitzsimons EJ, Mufti GJ, Williams R. Acquired sideroblastic anaemia induced by a copper-chelating agent. Int J Hematol [Internet]. 1996 [cited 2024 May 24];64:69–72. Available from: https://pubmed.ncbi.nlm.nih.gov/8757970/
    Back to article
  76. 76Litwin T, Dziezyc K, Karliński M, Chabik G, Czepiel W, Członkowska A. Early neurological worsening in patients with Wilson’s disease. J Neurol Sci [Internet]. 2015 [cited 2024 May 24];355:162–7. Available from: https://pubmed.ncbi.nlm.nih.gov/26071888/. DOI: 10.1016/j.jns.2015.06.010
    Back to article
  77. 77Kim B, Chung SJ, Shin HW. Trientine-induced neurological deterioration in a patient with Wilson’s disease. J Clin Neurosci [Internet]. 2013 [cited 2024 May 24];20:606–8. Available from: https://pubmed.ncbi.nlm.nih.gov/23274038/. DOI: 10.1016/j.jocn.2012.02.041
    Back to article
  78. 78Brewer GJ, Askari F, Lorincz MT, Carlson M, Schilsky M, Kluin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate – IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol. 2006;63:521–7. DOI: 10.1001/archneur.63.4.521
    Back to article
  79. 79Brewer GJ. Zinc and tetrathiomolybdate for the treatment of Wilson’s disease and the potential efficacy of anticopper therapy in a wide variety of diseases. Metallomics. 2009;1:199–206. DOI: 10.1039/b901614g
    Back to article
  80. 80Costa MI, Sarmento-Ribeiro AB, Gonçalves AC. Zinc: From Biological Functions to Therapeutic Potential. Int J Mol Sci [Internet]. 2023 [cited 2024 Jul 5];24. Available from: https://pubmed.ncbi.nlm.nih.gov/36902254/. DOI: 10.3390/ijms24054822
    Back to article
  81. 81Pal PK, Sinha S, Pillai S, Taly AB, Abraham RG. Successful treatment of tremor in Wilson’s disease by thalamotomy: A case report. Mov Disord [Internet]. 2007 [cited 2024 May 24];22:2287–90. Available from: https://pubmed.ncbi.nlm.nih.gov/17914724/. DOI: 10.1002/mds.21750
    Back to article
  82. 82Hölscher S, Leinweber B, Hefter H, Reuner U, Günther P, Weiss KH, et al. Evaluation of the symptomatic treatment of residual neurological symptoms in Wilson disease. Eur Neurol [Internet]. 2010 [cited 2024 May 24];64:83–7. Available from: https://pubmed.ncbi.nlm.nih.gov/20606453/. DOI: 10.1159/000316066
    Back to article
  83. 83Hefter H, Samadzadeh S. Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson’s Disease: Six Cases and Literature Review. Toxins (Basel) [Internet]. 2021 [cited 2024 May 24];13. Available from: https://pubmed.ncbi.nlm.nih.gov/33805281/. DOI: 10.3390/toxins13040241
    Back to article
  84. 84Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, et al. Dominant psychiatric manifestations in Wilson’s disease: a diagnostic and therapeutic challenge! J Neurol Sci [Internet]. 2008 [cited 2024 May 24];266:104–8. Available from: https://pubmed.ncbi.nlm.nih.gov/17904160/. DOI: 10.1016/j.jns.2007.09.009
    Back to article
  85. 85Hedera P. Treatment of Wilson’s disease motor complications with deep brain stimulation. Ann N Y Acad Sci [Internet]. 2014 [cited 2024 May 24];1315:16–23. Available from: https://pubmed.ncbi.nlm.nih.gov/24547944/. DOI: 10.1111/nyas.12372
    Back to article
  86. 86Dhar D, Holla VV, Kamble N, Yadav R, Srinivas D, Pal PK. Surgical Outcomes in Rare Movement Disorders: A Report of Seventeen Patients from India and Review of Literature. Tremor and Other Hyperkinetic Movements [Internet]. 2022 [cited 2024 May 24];12. Available from: /pmc/articles/PMC9231568/. DOI: 10.5334/tohm.693
    Back to article
  87. 87Lee SY, Yang HE, Yang HS, Lee SH, Jeung HW, Park YO. Neuromuscular Electrical Stimulation Therapy for Dysphagia Caused by Wilson’s Disease. Ann Rehabil Med [Internet]. 2012 [cited 2024 May 24];36:409. Available from: /pmc/articles/PMC3400883/. DOI: 10.5535/arm.2012.36.3.409
    Back to article
  88. 88Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: A review of what we have learned. World J Hepatol [Internet]. 2015 [cited 2024 May 24];7:2859–70. Available from: https://pubmed.ncbi.nlm.nih.gov/26692151/. DOI: 10.4254/wjh.v7.i29.2859
    Back to article
  89. 89Mahale RR, Stezin A, Prasad S, Kamble N, Holla VV, Netravathi M, et al. Clinical Spectrum, Radiological Correlation and Outcome of Movement Disorders in Wilson’s Disease. Tremor Other Hyperkinet Mov (N Y) [Internet]. 2023 [cited 2025 Feb 2];13. Available from: https://pubmed.ncbi.nlm.nih.gov/37840995/. DOI: 10.5334/tohm.794
    Back to article
  90. 90Krishnan N, Felice C, Rivera K, Pappin DJ, Tonks NK. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson’s disease. Genes Dev [Internet]. 2018 [cited 2025 Feb 3];32:944–52. Available from: https://pubmed.ncbi.nlm.nih.gov/29945887/. DOI: 10.1101/gad.314658.118
    Back to article
  91. 91Lichtmannegger J, Leitzinger C, Wimmer R, Schmitt S, Schulz S, Kabiri Y, et al. Methanobactin reverses acute liver failure in a rat model of Wilson disease. J Clin Invest [Internet]. 2016 [cited 2025 Feb 3];126:2721–35. Available from: https://pubmed.ncbi.nlm.nih.gov/27322060/. DOI: 10.1172/JCI85226
    Back to article
  92. 92Park SM, Vo K, Lallier M, Cloutier AS, Brochu P, Alvarez F, et al. Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson’s disease. Cell Transplant [Internet]. 2006 [cited 2024 May 24];15:13–22. Available from: https://pubmed.ncbi.nlm.nih.gov/16700326/. DOI: 10.3727/000000006783982188
    Back to article
  93. 93Xu WQ, Wang RM, Dong Y, Wu ZY. Emerging neurological symptoms after liver transplantation: A 6-year follow-up of an adolescent patient with Wilson’s disease. CNS Neurosci Ther [Internet]. 2022 [cited 2025 Feb 2];28:788–91. Available from: https://pubmed.ncbi.nlm.nih.gov/34997703/. DOI: 10.1111/cns.13798
    Back to article
  94. 94Ni W, Dong QY, Zhang Y, Wu ZY. Zinc monotherapy and a low-copper diet are beneficial in patients with Wilson disease after liver transplantation. CNS Neurosci Ther [Internet]. 2013 [cited 2025 Feb 2];19:905–7. Available from: https://pubmed.ncbi.nlm.nih.gov/24119323/. DOI: 10.1111/cns.12167
    Back to article
  95. 95Litwin T, Bembenek J, Antos A, Przybyłkowski A, Skowrońska M, Kurkowska-Jastrzębska I, et al. Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review. Acta Neurol Belg [Internet]. 2022 [cited 2025 Feb 2];122:505. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8986686/. DOI: 10.1007/s13760-022-01872-w
    Back to article
  96. 96Litwin T, Bembenek J, Antos A, Przybyłkowski A, Skowrońska M, Kurkowska-Jastrzębska I, et al. Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review. Acta Neurol Belg. 2022;122:505–18. DOI: 10.1007/s13760-022-01872-w
    Back to article
  97. 97Morgan SM, Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson’s disease. J Clin Apher [Internet]. 2012 [cited 2024 May 24];27:282–6. Available from: https://pubmed.ncbi.nlm.nih.gov/22718095/. DOI: 10.1002/jca.21239
    Back to article
  98. 98Irani AN, Malhi H, Slehria S, Gorla GR, Volenberg I, Schilsky ML, et al. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson’s disease. Mol Ther [Internet]. 2001 [cited 2024 May 24];3:302–9. Available from: https://pubmed.ncbi.nlm.nih.gov/11273771/. DOI: 10.1006/mthe.2001.0271
    Back to article
  99. 99Concilli M, Iacobacci S, Chesi G, Carissimo A, Polishchuk R. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease. Metallomics [Internet]. 2016 [cited 2025 Feb 3];8:920–30. Available from: https://pubmed.ncbi.nlm.nih.gov/27714068/. DOI: 10.1039/C6MT00148C
    Back to article
  100. 100Leng Y, Li P, Zhou L, Xiao L, Liu Y, Zheng Z, et al. Long-Term Correction of Copper Metabolism in Wilson’s Disease Mice with AAV8 Vector Delivering Truncated ATP7B. Hum Gene Ther [Internet]. 2019 [cited 2024 May 24];30:1494–504. Available from: https://pubmed.ncbi.nlm.nih.gov/31668086/. DOI: 10.1089/hum.2019.148
    Back to article
  101. 101Padula A, Petruzzelli R, Philbert SA, Church SJ, Esposito F, Campione S, et al. Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice. Mol Ther Methods Clin Dev [Internet]. 2022 [cited 2024 May 24];26:495–504. Available from: https://pubmed.ncbi.nlm.nih.gov/36092366/. DOI: 10.1016/j.omtm.2022.08.004
    Back to article
  102. 102Wei R, Yang J, Cheng CW, Ho WI, Li N, Hu Y, et al. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson’s disease. JHEP Rep [Internet]. 2021 [cited 2024 May 24];4. Available from: https://pubmed.ncbi.nlm.nih.gov/34877514/. DOI: 10.1016/j.jhepr.2021.100389
    Back to article
  103. 103Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: From liver transplantation to cell factory. J Hepatol [Internet]. 2015 [cited 2024 May 24];62:S157–69. Available from: https://pubmed.ncbi.nlm.nih.gov/25920085/. DOI: 10.1016/j.jhep.2015.02.040
    Back to article
  104. 104Göktaş MA, Yalcin N. Adherence to medical treatment for Wilson’s disease in children and adolescents: a cohort study from Turkey. Orphanet J Rare Dis. 2024;19:105. DOI: 10.1186/s13023-024-03113-0
    Back to article
  105. 105de Bem RS, Muzzillo DA, Deguti MM, Barbosa ER, Werneck LC, Teive HAG. Wilson’s disease in southern Brazil: a 40-year follow-up study. Clinics [Internet]. 2011 [cited 2024 May 24];66:411. Available from: /pmc/articles/PMC3072000/. DOI: 10.1590/S1807-59322011000300008
    Back to article
  106. 106Kawai K, Atarashi Y, Takahara T, Kudo H, Tajiri K, Tokimitsu Y, et al. Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient. Clin J Gastroenterol [Internet]. 2009 [cited 2024 May 24];2:119–24. Available from: https://pubmed.ncbi.nlm.nih.gov/26192177/. DOI: 10.1007/s12328-008-0056-6
    Back to article
  107. 107Brewer GJ, Yuzbasiyan-Gurkan V, Young AB. Treatment of Wilson’s disease. Semin Neurol [Internet]. 1987 [cited 2025 Feb 2];7:209–20. Available from: https://pubmed.ncbi.nlm.nih.gov/3332455/. DOI: 10.1055/s-2008-1041420
    Back to article
DOI: https://doi.org/10.5334/tohm.938 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jul 28, 2024
Accepted on: Feb 3, 2025
Published on: May 5, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Wilson’s disease,
Movement disorders,
Treatment,
Outcome,
Neurological and/or hepatic WD

© 2025 V. H. Ganaraja, Vikram V. Holla, Pramod Kumar Pal, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 15 (2025): Issue 1Next article